Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Incyte Corporation
Fred Hutchinson Cancer Center
CRISPR Therapeutics
Incyte Corporation
Acerta Pharma BV
National Institutes of Health Clinical Center (CC)
Genmab
Stanford University
Thomas Jefferson University
Gilead Sciences
Mayo Clinic
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
AIDS Malignancy Consortium
Gamida Cell ltd
Aprea Therapeutics
Oncternal Therapeutics, Inc
Memorial Sloan Kettering Cancer Center
Celgene
Altor BioScience
Nordic Nanovector
Takeda
Celgene
M.D. Anderson Cancer Center
City of Hope Medical Center
Cellestia Biotech AG
National Cancer Institute (NCI)
Hoffmann-La Roche
University of Nebraska
University of Nebraska
University of Nebraska
Bellicum Pharmaceuticals
Asana BioSciences
Bristol-Myers Squibb
Genentech, Inc.
Atara Biotherapeutics
Precision BioSciences, Inc.
Molecular Templates, Inc.
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Spectrum Pharmaceuticals, Inc
Gamida Cell ltd
Columbia University
City of Hope Medical Center
Weill Medical College of Cornell University
Novartis
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)